Vela Pharmaceuticals, Inc.
Records under this name other than patents Vela Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Vela Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,683,072 | Compositions and methods for treatment of irritable bowel syndrome and nonulcer dyspepsia Term ended Term ended Feb 4, 2023 · From the USPTO record | Term ended | Term ended Feb 4, 2023 | From the USPTO record |
| US 6,649,607 | Compositions and methods for treating or preventing convulsions or seizures Formerly held Term ended Term ended Nov 9, 2021 · From the USPTO record | Term ended | Term ended Nov 9, 2021 | From the USPTO record |
| US 7,541,355 | Conversion process for 2,3-benzodiazepine enantiomers Lapsed on the fee record Ended Jun 2, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jun 2, 2021 | From the USPTO record |
| US 6,358,944 | Methods and compositions for treating generalized anxiety disorder Term ended Term ended Aug 23, 2020 · From the USPTO record | Term ended | Term ended Aug 23, 2020 | From the USPTO record |
| US 6,395,788 | Methods and compositions for treating or preventing sleep disturbances and associated illnesses using very low doses of cyclobenzaprine Formerly held Term ended Term ended Aug 11, 2020 · From the USPTO record | Term ended | Term ended Aug 11, 2020 | From the USPTO record |
| US 6,541,523 | Methods for treating or preventing fibromyalgia using very low doses of cyclobenzaprine Formerly held Term ended Term ended Aug 11, 2020 · From the USPTO record | Term ended | Term ended Aug 11, 2020 | From the USPTO record |
| US 6,080,736 | Methods and compositions for treating and preventing anxiety and anxiety disorders using optically pure (R) tofisopam Formerly held Term ended Term ended Oct 27, 2019 · From the USPTO record | Term ended | Term ended Oct 27, 2019 | From the USPTO record |
| US 7,078,398 | Compositions and methods for treating or preventing convulsions or seizures Lapsed on the fee record Ended Jul 18, 2018 · From the USPTO record | Lapsed on the fee record | Ended Jul 18, 2018 | From the USPTO record |
| US 7,265,106 | Method for isolating (R)-tofisopam Lapsed on the fee record Ended Sep 4, 2015 · From the USPTO record | Lapsed on the fee record | Ended Sep 4, 2015 | From the USPTO record |
| US 7,745,431 | Pharmaceutical composition of 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5H-2,3-benzodiazepine and uses thereof Lapsed on the fee record Ended Jun 29, 2014 · From the USPTO record | Lapsed on the fee record | Ended Jun 29, 2014 | From the USPTO record |